Cyclarity’s head of clinical affairs on targeting atherosclerosis, preclinical progress and accelerating trials via UK regulatory pathway.
Cyclarity’s head of clinical affairs on targeting atherosclerosis, preclinical progress and accelerating trials via UK regulatory pathway.
Very exciting